Atorvastatin Combined with Ezetimibe in the Treatment of Patients with Hypercholesterolemia
Qibing Wang
Abstract
Qibing Wang
Abstract
Objective:To investigate the efficacy of atorvastatin combined with ezetimibe in the treatment of patients with hypercholesterolemia.Methods:Forty patients(23 males,17 females,aged 58±12 yrs)with severe hypercholesterolemia who failed to achieve lipid lowering target level(LDL-C2.6 mmol/L)after 6 months treatment with atorvastatin(20mg,Qd)were added with ezetimibe(10 mg,Qd)for 3 months observation.Results:After 6 months treatment with atorvastatin,the lipids of TC,LDL-C,TG,ApoB and Lp(a)were decreased and HDL-C elevated remarkably than those at baseline,and with P0.01 respectively.When combined with ezetimibe for 3 months,the lipid level of TC,LDL-C and ApoB was reduced than that of merely using atorvastatin,and with P0.01 in respect.No significant abnormalities were found in particular with AST,ALT and CK during this therapy.Conclusion:Atorvastatin combined with ezetimibe can produce further lipid lowering effects than only atorvastatin in patient with severe hypercholesterolemia.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the efficacy of atorvastatin combined with ezetimibe in the treatment of patients with hypercholesterolemia.Methods:Forty patients(23 males,17 females,aged 58±12 yrs)with severe hypercholesterolemia who failed to achieve lipid lowering target level(LDL-C2.6 mmol/L)after 6 months treatment with atorvastatin(20mg,Qd)were added with ezetimibe(10 mg,Qd)for 3 months observation.Results:After 6 months treatment with atorvastatin,the lipids of TC,LDL-C,TG,ApoB and Lp(a)were decreased and HDL-C elevated remarkably than those at baseline,and with P0.01 respectively.When combined with ezetimibe for 3 months,the lipid level of TC,LDL-C and ApoB was reduced than that of merely using atorvastatin,and with P0.01 in respect.No significant abnormalities were found in particular with AST,ALT and CK during this therapy.Conclusion:Atorvastatin combined with ezetimibe can produce further lipid lowering effects than only atorvastatin in patient with severe hypercholesterolemia.
Key concepts: Atorvastatin, Ezetimibe, Medicine, Apolipoprotein B, Internal medicine, Familial hypercholesterolemia, Ldl cholesterol, Gastroenterology